ARCHIVES

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Intends To Extend OSCC Two More Years

October 3, 1986

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting.

April 29, 2005

NCI Pilot to Speed Phase III Trials Deemed Unsuccessful, Will Be Shut Down

November 22, 2002

OMB Reprogramming Ban Criticized

September 20, 1985